SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and developmentNicholas Murgolo, David B. Olsen, Alex G. Therien et al.|PLoS Pathogens|2021Cited by 215
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Alan F. Cowman, Wai‐Hong Tham et al.|Cell Host & Microbe|2020Cited by 167
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinRonald E. Painter, Katherine Young, Gregory C. Adam et al.|Chemistry & Biology|2015Cited by 40
Discovery and Structure–Activity-Relationship Study of <i>N</i>-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-<scp>d</scp>-ribose 2′-OxidaseSangmi Oh, Clifton E. Barry, Yumi Park et al.|Journal of Medicinal Chemistry|2018Cited by 37
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N. Hodder, Alan F. Cowman, Janni Christensen et al.|Structure|2022Cited by 32